EGFR and hTERT mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications

R. Cherneva, O. Georgiev, D. Petrova, B. Rukova, D. Toncheva (Toncheva, Bulgaria)

Source: Annual Congress 2010 - Biomarkers for lung cancer
Session: Biomarkers for lung cancer
Session type: Thematic Poster Session
Number: 3235

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Cherneva, O. Georgiev, D. Petrova, B. Rukova, D. Toncheva (Toncheva, Bulgaria). EGFR and hTERT mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications. Eur Respir J 2010; 36: Suppl. 54, 3235

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
EGF-receptor mutation in non-small cell lung cancer – Experiences by routine molecular testing in a German lung cancer centre
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

TTF-1 in advanced SCLC – Diagnostic and prognostic relevance
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

KRAS mutations in non-small cell lung cancer (NSCLC) – Experiences by routine molecular testing in a German lung cancer centre
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011

HER2/Neu overexpression as independent negative prognostic factor for non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010

Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Octogenarians with non-small cell lung carcinoma – Advanced disease
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012

Survival outcomes in advance non-small cell lung cancer – A developing country scenario
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011

Prognostic value of p21 protein expression in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 674s
Year: 2004

The prognostic significance of sVEGF levels in patients(pts) with Non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 363s
Year: 2003

FEV1 is not a prognostic marker in operated patients with stage I or II non-small cell lung cancer (NSCLC)
Source: Annual Congress 2011 - Surgery for lung cancer: pre-operative evaluation and results
Year: 2011


Lung function and quality of life after surgical treatment of non-small cell lung cancer – preliminary results
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009


Is MIF -173G/C polymorphism associated with in non-small cell lung cancer (NSCLC) susceptibility?
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Validation of the prognostic value of growth pattern classification in operated non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Year: 2010

Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications
Source: Eur Respir J 2009; 33: 127-133
Year: 2009



beta-F1-ATPase expression as a prognostic factor for resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012

Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro
Year: 2020


Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Prognostic value of il-6 and TNF-alfa serum concentration in advanced non-small lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 251s
Year: 2003